Consultancy contract with Decoy Therapeutics

AI SummaryClose X

hVIVO plc has secured a consultancy contract with Decoy Therapeutics to support the development of its respiratory antiviral candidates, providing services including translational modelling, regulatory strategy, and CMC consulting. This engagement is designed to advance Decoy's clinical development strategy, with potential for hVIVO to conduct future early proof-of-concept and follow-on studies. The agreement highlights hVIVO's integrated platform capabilities, assisting biotechnology companies in navigating the complex path to clinical development.

Disclaimer*

Companies

Hvivo (HVO)
UK 100

Latest directors dealings